Regulatory milestones

Almirall S.A. (Madrid:ALM) was off €0.10 to €10.08 last week on a double dose of negative news in Germany. The country's Federal Joint Committee (G-BA) said Bretaris/Eklira Genuiar aclidinium bromide has "no additional benefit" over Spiriva HandiHaler tiotropium for chronic obstructive pulmonary disease (COPD).